Global Platform for Access to Childhood Cancer Medicines

St. Jude Children’s Research Hospital believes no child should die in the dawn of life.

That means every child, everywhere.

Logo for St. Jude / WHO collaboration

Access to safe and effective medicines is a barrier to cancer care worldwide. Many hospitals struggle to reliably access affordable, high-quality medications for their children with cancer.

map of world showing survival rates for pediatric cancer

Estimated childhood cancer 5-year net survival by country (2015-2019). The lack of consistent access to essential childhood cancer medicines is an important factor in a lower survival rate in many low- and middle-income countries. SOURCE: Ward ZJ, Yeh JM, Bhakta N, Frazier AL, Girardi F, Atun R. Global childhood cancer survival estimates and priority-setting: a simulation-based analysis. Lancet Oncol. 2019;20(7):972–83.

The Challenge

icon for availability


of essential cancer medicines around the globe is inconsistent due to supply and demand issues and complicated regulations.

icon of medicine


of medicines is threatened when governments and administrations favor lowest-cost bids.

icon for medical costs


of childhood cancer medicines is often excluded from budgets, creating financial hardship for families in low- and middle- income countries.


71% of low-income countries report general shortages in cancer medicines. At the 70th World Health Assembly, global health leaders adopted a new resolution. It called for better access to essential medicines and other measures for all with cancer.


The Solution

Introducing the Global Platform for Access to Childhood Cancer Medicines

icon of star

St. Jude and World Health Organization (WHO) are creating the platform to provide children with cancer with an uninterrupted supply of quality cancer medicines.

icon of network

The platform will bring St. Jude, WHO, governments, the pharmaceutical industry, non-governmental organizations and the nonprofit sector together to ensure quality and effective medicines are available to treat childhood cancer. This effort will increase global visibility and predictability of the market for childhood cancer medicines.

icon of heart and hands

In 6 years, approximately 120,000 children in low- and middle- income countries could benefit.

The Global Platform for Access to Childhood Cancer Medicines offers a new approach to give childhood cancer patients worldwide access to life-saving treatment.